Two faces of drug repurposing data in machine learning-driven structure-based virtual screening supported by interaction fingerprints.

Publication date: Jul 06, 2026

Ensemble docking is a prominent source of protein-ligand complex structures, which could be conveniently analyzed with interaction fingerprints approach in a machine learning framework. Nevertheless, the chemical nature and provenance of the source data libraries used for model development may influence the predictive ability. We assessed the performance of SARS-CoV-2 main protease (Mpro) inhibitors classification by random forest models trained on different fingerprint implementations using three inhibitor libraries, comprising drug repurposing data or compounds rationally designed as Mpro inhibitors. Models trained on drug repurposing data showed a low prediction performance on their own, while infusion of these data into libraries with specific inhibitors greatly improved applicability domains of the models. Our results highlight the importance of balanced dataset preparation for machine learning applications in medicinal chemistry, especially when relied on drug repurposing experiments.

Semantics

Original Article